7 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 7 of 7 clinical reviews.
Clinician-focused summary of statin prescribing across special populations: pregnancy, pediatrics, hepatic/renal impairment, older adults, and race-based pharmacogenomic considerations for ASCVD prevention.
A clinical reference for prescribers and pharmacists on managing statin adverse events: myopathy, hepatotoxicity, new-onset diabetes, and drug interactions, with specific monitoring thresholds and dose-adjustment protocols.
A complete MD/PharmD-level guide to HMG-CoA reductase inhibitor pharmacology, prescribing tiers, prior-authorization strategy, and billing codes for statins used in ASCVD prevention.
A full clinical reference on HMG-CoA reductase inhibitors (statins): mechanism, dosing, ASCVD risk stratification, lab monitoring protocols, drug interactions, and adverse effect management. Written at MD/PharmD level.
A prescriber-level monograph covering the statin drug class, including mechanism, pharmacokinetics, landmark trial data, safety profiles, drug interactions, and clinical decision-making for ASCVD prevention.
A prescriber-level guide to choosing among statins, atorvastatin, rosuvastatin, pitavastatin, and others, based on potency, drug interactions, renal function, and ASCVD risk category.
A prescriber-level guide to statin titration, tapering, dose adjustments, and switching strategies for HMG-CoA reductase inhibitors, with clinical trial evidence and guideline-based thresholds.